These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 17085372)

  • 21. [Hormone replacement therapy in menopause and risk of breast cancer].
    Fournier A; Hill C; Clavel-Chapelon F
    Bull Cancer; 2003 Oct; 90(10):821-31. PubMed ID: 14706912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controversies in HRT.
    Teede HJ
    Aust Fam Physician; 2002 May; 31(5):413-8. PubMed ID: 12043543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormone replacement therapy use and variations in the risk of breast cancer.
    Opatrny L; Dell'Aniello S; Assouline S; Suissa S
    BJOG; 2008 Jan; 115(2):169-75; discussion 175. PubMed ID: 18081598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current opinions and understandings of menopausal women about hormone replacement therapy (HRT)-the University of Florida experience.
    Levens E; Williams RS
    Am J Obstet Gynecol; 2004 Aug; 191(2):641-6; discussion 646-7. PubMed ID: 15343254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are older breast carcinoma survivors willing to take hormone replacement therapy?
    Ganz PA; Greendale GA; Kahn B; O'Leary JF; Desmond KA
    Cancer; 1999 Sep; 86(5):814-20. PubMed ID: 10463980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The thoughts of breast cancer survivors regarding the need for starting hormone replacement therapy.
    Trinh XB; Peeters F; Tjalma WA
    Eur J Obstet Gynecol Reprod Biol; 2006 Feb; 124(2):250-3. PubMed ID: 16144734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormone replacement therapy in postmenopausal women.
    Staren ED; Omer S
    Am J Surg; 2004 Aug; 188(2):136-49. PubMed ID: 15249239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy.
    Schuetz F; Diel IJ; Pueschel M; von Holst T; Solomayer EF; Lange S; Sinn P; Bastert G; Sohn C
    Am J Obstet Gynecol; 2007 Apr; 196(4):342.e1-9. PubMed ID: 17403414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormone replacement therapy and breast cancer: what are the facts?
    MacLennan AH; Smith M
    Med J Aust; 1995 Nov; 163(9):483-5. PubMed ID: 7476639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The management of menopausal symptoms in women with breast cancer.
    Jubelirer SJ
    W V Med J; 1995 Feb; 91(2):54-6. PubMed ID: 7610643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy.
    Katalinic A; Rawal R
    Breast Cancer Res Treat; 2008 Feb; 107(3):427-30. PubMed ID: 17453336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormone replacement therapy and breast cancer risk in California.
    Coombs NJ; Taylor R; Wilcken N; Fiorica J; Boyages J
    Breast J; 2005; 11(6):410-5. PubMed ID: 16297085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of hormone replacement therapy on the histologic subtype of breast cancer.
    Zanetti-Dällenbach RA; Krause EM; Lapaire O; Gueth U; Holzgreve W; Wight E
    Arch Gynecol Obstet; 2008 Nov; 278(5):443-9. PubMed ID: 18335229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?
    Holtorf K
    Postgrad Med; 2009 Jan; 121(1):73-85. PubMed ID: 19179815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormone replacement therapy after breast cancer: attitudes of women eligible in a randomized trial.
    Wallberg B; von Schoultz E; Bolund C; Bergh J; Wilking N
    Climacteric; 2009 Dec; 12(6):478-89. PubMed ID: 19905900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hormonal replacement therapy in menopause and the risk of breast cancer].
    Lê MG
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(7):684-7. PubMed ID: 8991901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Historical perspective of hormone replacement therapy].
    Chanson P
    Rev Prat; 2005 Feb; 55(4):369-75. PubMed ID: 15828614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Is the clinical profile of women treated with tibolone similar to that of women receiving a classical estrogen-progestogen therapy? Data from a nationwide survey in France].
    Jamin C; Bourg F; Legeai J; Senoussi S
    Gynecol Obstet Fertil; 2006 Mar; 34(3):224-32. PubMed ID: 16513401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Case in point. Counseling about hormone replacement therapy.
    Mahon SM
    Oncol Nurs Forum; 1998 May; 25(4):663-4. PubMed ID: 9599344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.